{"SPADE_UN_10953": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0077289 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0077289_A1", "Patent Type": "Patent Application", "Publication Date": "2003-4-24", "Family Info": "CN1309417C,CN1503628A,WO2002064057A2,WO2002064057A3", "Patent Title": "Use of cell-penetrating peptides to generate antitumor immunity.", "Abstract": "The present invention is directed to methods and compositions for enhancing an immune response in an animal to a disease by administering an immune effector cell comprising a cell penetrating peptide associated with an antigen for the disease. In a specific embodiment, the immune effector cell is a dendritic cell comprising a cell penetrating peptide associated with an antitumor antigen for cancer immunotherapy."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10953", "Sequence": "GALFLGWLGAAGSTMGAWSQPKKKRKV", "Sequence Length": 27, "Peptide Name": "Sequence 8 from Patent US 20030077289", "Source": "Synthetic construct", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "GAK", "Absent Amino Acids": "CDEHINOUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 14, "Positive Residues": 5, "Negative Residues": 0, "Mass": 2846.35, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": -0.14, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_10969", "Similarity": 1.0, "Sequence": "GALFLGWLGAAGSTMGAPKKKRKV"}, {"SPADE_ID": "SPADE_N_04905", "Similarity": 1.0, "Sequence": "PKKKRKV"}, {"SPADE_ID": "SPADE_N_06987", "Similarity": 1.0, "Sequence": "PKKKRKVALWKTLLKKVLKA"}]}}}